コンテンツへスキップ
Merck

Balloon-occluded retrograde transvenous obliteration of gastric varices.

AJR. American journal of roentgenology (2012-09-22)
Amish Patel, Aaron M Fischman, Wael E Saad
要旨

The purpose of this review is to describe the clinical factors related to balloon-occluded retrograde transvenous obliteration, including the preparation needed, the technique and challenges, and the outcomes. Although the procedure can be performed when transjugular intrahepatic portosystemic shunt is contraindicated or when endoscopic management fails, balloon-occluded retrograde transvenous obliteration is successful as a first-line or second-line therapy. Gastric variceal rebleeding rates are low and serious complications are rare. Randomized controlled trials are required to evaluate the superiority of this procedure over other methods of treating gastric varices and to determine which sclerosant should be used. In the near future, this procedure may play a larger role in emergency care and in the management of nongastric varices.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
デカエチレングリコールモノドデシルエーテル, nonionic surfactant
Sigma-Aldrich
Thesit®, for membrane research
Sigma-Aldrich
硫酸テトラデシル ナトリウム塩, 95%
Sigma-Aldrich
Brij® L23 溶液, 30 % (w/v) in H2O
Sigma-Aldrich
Brij® L23, main component: tricosaethylene glycol dodecyl ether
Sigma-Aldrich
Brij® L4, average Mn ~362
Sigma-Aldrich
Brij® L23, suitable for Stein-Moore chromatography
Sigma-Aldrich
Brij® L4, average Mn ~362
Sigma-Aldrich
Brij® L23